Predictive Oncology Inc.
POAI
$6.00
$0.458.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -84.33M | -9.78M | -10.89M | -12.66M | -13.97M |
| Total Depreciation and Amortization | 1.08M | 1.07M | 1.05M | 1.04M | 983.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 74.70M | 163.60K | 1.11M | 672.30K | 905.90K |
| Change in Net Operating Assets | 666.50K | -855.80K | -571.90K | -1.00M | -809.00K |
| Cash from Operations | -7.88M | -9.40M | -9.30M | -11.96M | -12.89M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -3.00K | 12.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 625.00K | 657.00K | 650.50K | 25.50K | 17.30K |
| Cash from Investing | 625.00K | 657.00K | 650.50K | 22.50K | 29.80K |
| Total Debt Issued | 264.00K | 264.00K | 275.10K | 275.10K | 275.10K |
| Total Debt Repaid | -272.50K | -275.10K | -313.10K | -425.50K | -339.50K |
| Issuance of Common Stock | 4.61M | 4.43M | 7.54M | 4.96M | 4.96M |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -240.90K | -499.90K | -950.60K | -870.90K | -870.90K |
| Cash from Financing | 4.36M | 3.92M | 6.55M | 3.94M | 4.02M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.90M | -4.83M | -2.09M | -7.99M | -8.84M |